Diagnostics Makers Aim To Produce 25 Million COVID-19 Tests By End Of April
The head of the largest medical device lobby group told reporters the industry hopes to get 25 million diagnostic tests produced by the end of the month to fight the ongoing coronavirus pandemic in the US.
You may also be interested in...
An alert from the agency warns that the tests, which have become widely used for their speed and portability, carry a risk of false positives.
Medtech industry group AdvaMed has developed a registry to share data on how many COVID-19 diagnostic tests are available and where they are, with a goal of foreseeing and nipping in the bud potential test shortages. Thirteen diagnostic manufacturers – including Abbott, Roche, Siemens and Thermo Fisher Scientific – have partnered with AdvaMed on the initiative.
Despite the White House’s insistence it has been quick and decisive in its response to the COVID-19 crisis, former FDA commissioner Scott Gottlieb – who has been advising the administration – said on 6 May that the government should’ve responded months sooner to ensure there was enough testing.